Journal of Industrial and Engineering Chemistry, Vol.43, 150-157, November, 2016
Pluronic mimicking fluorescent carbon nanoparticles conjugated with doxorubicin via acid-cleavable linkage for tumor-targeted drug delivery and bioimaging
E-mail:
Fluorescent carbon nanoparticles based target drug delivery with bio-imaging systems offer tremendous scope for future. We described Pluronic mimicking fluorescent nanoparticles (Plu-FNPs) surface decorated doxorubicin (DOX) via acid-cleavable hydrazone linkages with tumor target folic acid (FA) [Plu-FNPs-FA-DOX]. The acid labile of hydrazine linkage to DOX can easily break off by controlled pH inducing release of conjugated DOX at site of over-expressed folate receptors (FR). This nanoparticle system can deliver DOX to the target FR and trace the delivery pathway of cancer cells. The approaching platform demonstrates the selectivity and sensitivity of molecular targets, thereby able to maximize the therapeutic efficiency.
Keywords:Fluorescent carbon nanoparticles;Folic acid;Doxorubicin;Target delivery;Bioimaging;Pluronic
- Faraji AH, Wipf P, Bioorg. Med. Chem., 17, 2950 (2009)
- LaVan DA, Lynn DM, Langer R, Nat. Rev. Drug Discov., 1, 77 (2002)
- Kang EB, Lee JE, Jeong JH, Lee G, In I, Park SY, J. Ind. Eng. Chem., 33, 336 (2016)
- Yoo HS, Lee KH, Oh JE, Park TG, J. Control. Release, 68, 419 (2000)
- Patra S, Roy E, Madhuri R, Sharma PK, Biomater. Sci., 4, 418 (2016)
- Sharker SM, Kim SM, Lee JE, Choi KH, Shin G, Lee S, Lee KD, Jeong JH, Lee H, Park SY, J. Control. Release, 217, 211 (2015)
- Kim J, Lee JE, Lee SH, Yu JH, Lee JH, Park TG, Hyeon T, Adv. Mater., 20(3), 478 (2008)
- Sharker SM, Khatun M, Uddin N, Hasan MS, Chakma S, Rahman AA,, Curr. Drug Ther., 4, 144 (2009)
- Sharker SM, Kim SM, Lee JE, Jeong JH, In I, Lee KD, Lee H, Park SY, Nanoscale, 7, 5468 (2015)
- Jeong CJ, Lee G, In I, Park SY, Luminescence, 31, 897 (2015)
- Wang H, Shen J, Li Y, Wei Z, Cao G, Gai Z, Hong K, Banerjee P, Zhou S, Biomater. Sci., 2, 915 (2014)
- Sharker SM, Kim SM, Kim SH, In I, Lee H, Park SY, J. Mater. Chem. B, 3, 5833 (2015)
- Misra SK, Ohoka A, Kolmodin NJ, Pan D, Mol. Pharm., 12, 375 (2015)
- Leamon CP, Reddy JA, Adv. Drug Deliv. Rev., 56, 1127 (2004)
- Hruby M, Konak C, Ulbrich K, J. Control. Release, 103, 137 (2005)
- Lee Y, Park SY, Mok H, Park TG, Bioconjugate Chem., 19, 525 (2008)
- Sharker SM, Lee JE, Kim SH, Jeong JH, In I, Lee H, Park SY, Biomaterials, 61, 229 (2015)
- Gou P, Liu W, Mao W, Tang J, Shen Y, J. Mater. Chem. B, 1, 284 (2013)
- Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K, Mol. Biosyst., 1, 242 (2005)
- Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC, Adv. Drug Deliv. Rev., 66, 2 (2014)
- Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC, Chem. Soc. Rev., 41, 2971 (2012)
- Sharker SM, Jeong CJ, Kim SM, Lee JE, Jeong JH, In I, Lee H, Park SY, Chem. Asian J., 9, 2921 (2014)
- Pourjavadi A, Tehrani ZM, Jokar S, J. Ind. Eng. Chem., 28, 45 (2015)
- Cho K, Wang X, Nie S, Chen Z, Shin DM, Clin. Cancer Res., 14, 1310 (2008)
- Abdel-Mottaleb MM, Beduneau A, Pellequer Y, Lamprecht A, Int. J. Pharm., 494, 471 (2015)
- Kumar R, Kulkarni A, Nagesha DK, Sridhar S, Theranostics, 2, 714 (2012)
- Li X, Shao J, Qin Y, Shao C, Zheng T, Ye L, J. Mater. Chem., 21, 7966 (2011)
- Rouhollah K, Pelin M, Serap Y, Gozde U, Ufuk G, J. Pharm. Sci., 102, 1825 (2013)
- Nguyen DH, Bae JW, Choi JH, Lee JS, Park KD, J. Bioact. Compat. Polym., 28, 341 (2013)
- Unsoy G, Khodadust R, Yalcin S, Mutlu P, Gunduz U, Eur. J. Pharm. Sci., 62, 243 (2014)
- Zhang XJ, Chen DW, Ba S, Zhu J, Zhang J, Hong W, Zhao XL, Hu HY, Qiao MX, Biomacromolecules, 15(11), 4032 (2014)
- Kim K, Lee CS, Na K, Chem. Commun., 52, 2839 (2016)